Mutual of America Capital Management LLC lessened its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 0.5% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 18,767 shares of the semiconductor company’s stock after selling 91 shares during the period. Mutual of America Capital Management LLC’s holdings in Synopsys were worth $9,621,000 at the end of the most recent quarter.
A number of other large investors have also modified their holdings of the stock. Quotient Wealth Partners LLC purchased a new stake in shares of Synopsys during the second quarter worth $268,000. Chevy Chase Trust Holdings LLC increased its position in shares of Synopsys by 0.7% during the second quarter. Chevy Chase Trust Holdings LLC now owns 81,971 shares of the semiconductor company’s stock worth $42,025,000 after acquiring an additional 600 shares during the period. Angeles Wealth Management LLC purchased a new stake in shares of Synopsys during the second quarter worth $478,000. Applied Finance Capital Management LLC increased its position in shares of Synopsys by 3.9% during the second quarter. Applied Finance Capital Management LLC now owns 1,931 shares of the semiconductor company’s stock worth $990,000 after acquiring an additional 73 shares during the period. Finally, Mattson Financial Services LLC increased its position in shares of Synopsys by 29.6% during the second quarter. Mattson Financial Services LLC now owns 4,260 shares of the semiconductor company’s stock worth $2,184,000 after acquiring an additional 973 shares during the period. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Insider Activity at Synopsys
In related news, Director Robert G. Painter purchased 350 shares of Synopsys stock in a transaction that occurred on Thursday, September 11th. The stock was purchased at an average cost of $425.44 per share, with a total value of $148,904.00. Following the completion of the transaction, the director directly owned 2,291 shares in the company, valued at approximately $974,683.04. The trade was a 18.03% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of the company’s stock in a transaction dated Monday, September 22nd. The shares were sold at an average price of $500.90, for a total transaction of $4,945,385.70. Following the completion of the sale, the chief accounting officer directly owned 20,520 shares of the company’s stock, valued at $10,278,468. The trade was a 32.48% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 30,894 shares of company stock valued at $16,760,783 in the last ninety days. 0.62% of the stock is currently owned by insiders.
Synopsys Price Performance
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share for the quarter, missing analysts’ consensus estimates of $3.75 by ($1.45). Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The company had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.77 billion. During the same period last year, the firm earned $3.43 earnings per share. Synopsys’s revenue was up 14.0% on a year-over-year basis. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. As a group, sell-side analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current year.
Wall Street Analyst Weigh In
A number of analysts have recently weighed in on the company. Citigroup lowered Synopsys from a “neutral” rating to an “underperform” rating in a research report on Wednesday, September 10th. Zacks Research lowered Synopsys from a “hold” rating to a “strong sell” rating in a research report on Friday, September 12th. Piper Sandler cut their price objective on Synopsys from $660.00 to $630.00 and set an “overweight” rating on the stock in a research report on Wednesday, September 10th. JPMorgan Chase & Co. lowered their target price on shares of Synopsys from $685.00 to $600.00 and set an “overweight” rating for the company in a research note on Wednesday, September 10th. Finally, BNP Paribas began coverage on shares of Synopsys in a research note on Thursday, October 2nd. They set an “underperform” rating and a $425.00 target price for the company. Ten investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat.com, Synopsys has an average rating of “Hold” and an average price target of $569.67.
View Our Latest Report on Synopsys
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Recommended Stories
- Five stocks we like better than Synopsys
- What is MarketRank� How to Use it
- JPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall?
- Using the MarketBeat Stock Split Calculator
- Snap-on Incorporated: Snap It Up Quick, New Highs Will Come Soon
- How to Short a Stock in 5 Easy StepsĀ
- As Global Renewables Surpass Coal, This ETF Offers Smart Exposure
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.